F2G raised $70 million in a financing round co-led by new investors Forbion and Sofinnova Partners

Biotech Health services Pharma

Investments

01 August 2022

F2G (company)

Biotech Health services Pharma

Total investments received (USD): 170m

Round value (USD): 70m

Round investors: Advent Life Sciences Morningside Ventures Forbion Capital Partners Novo A/S Sofinnova Partners Cowen Healthcare Investments

Company: F2G

Industry: Biotech Health services Pharma

Health services Pharma

Investments 04 December 2022

Health services Pharma

Investments 06 November 2022

Biotech Health services Pharma

Investments 19 September 2022

Biotech Health services

Investments 02 July 2022

Biotech Health services

Investments 24 June 2022